Eisai to Present Latest Data on Lemborexant at SLEEP 2023
Tokyo-based Eisai will present eight poster presentations on its orexin receptor antagonist lemborexant (Dayvigo) at SLEEP 2023.
United States Eisai Co Ltd Tokyo Based Eisai Co Ltd Long Term Efficacy Objective Sleep Measures Clinical Practice
Source: sleepreviewmag.com